Your browser doesn't support javascript.
loading
Addition of Narrow-Band UVB Phototherapy to Ruxolitinib Cream in Patients With Vitiligo.
Pandya, Amit G; Harris, John E; Lebwohl, Mark; Hamzavi, Iltefat H; Butler, Kathleen; Kuo, Fiona I; Wei, Shaoceng; Rosmarin, David.
Afiliación
  • Pandya AG; Palo Alto Foundation Medical Group, Sutter Health, Sunnyvale, California, USA; Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Electronic address: amit.pandya@utsouthwestern.edu.
  • Harris JE; Department of Dermatology, UMass Medical School, Worcester, Massachusetts, USA.
  • Lebwohl M; Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Hamzavi IH; Department of Dermatology and Skin Care, Henry Ford Medical Center, Detroit, Michigan, USA.
  • Butler K; Incyte, Wilmington, Delaware, USA.
  • Kuo FI; Incyte, Wilmington, Delaware, USA.
  • Wei S; Incyte, Wilmington, Delaware, USA.
  • Rosmarin D; Department of Dermatology, Tufts Medical Center, Boston, Massachusetts, USA.
J Invest Dermatol ; 142(12): 3352-3355.e4, 2022 12.
Article en En | MEDLINE | ID: mdl-35787401

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia Ultravioleta / Vitíligo / Hipopigmentación Límite: Humans Idioma: En Revista: J Invest Dermatol Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia Ultravioleta / Vitíligo / Hipopigmentación Límite: Humans Idioma: En Revista: J Invest Dermatol Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos